$AARD
Aardvark Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
AARD chart
What traders are saying about $AARD
Latest postsAardvark Therapeutics, Inc. news
- Form 4 Aardvark Therapeutics Inc: Tien-Li Lee (Director, 10% Owner, CEO) For: 6 November
Investing.com Canada ·
- Aardvark Therapeutics, Inc. expected to post a loss of 72 cents a share - Earnings Preview
TradingView ·
- Raymond James Downgrades Aardvark Therapeutics to Market Perform
www.marketscreener.com ·
- Agilent Technologies' Q4 Earnings on Deck: What's in Store for the Stock?
Yahoo Finance ·
- Raymond James Downgrades Aardvark Therapeutics(AARD.US) to Hold Rating
Moomoo ·
- Raymond James downgrades Aardvark Therapeutics stock rating on FDA path concerns
Investing.com ·
- Aardvark Therapeutics, Inc. (AARD) Seasonal returns chart
Yahoo Finance UK ·
- Aardvark Therapeutics Inc. (AARD) Stock Price | Live Quotes & Charts | NASDAQ
Timothy Sykes ·
- Sector Update: Healthcare Stocks Fall Late Afternoon
Yahoo Finance ·
- Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials
Yahoo Finance ·
- Aardvark Therapeutics stock surges as FDA lifts clinical hold
Yahoo Finance ·
- Aardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast to Review the Available Exploratory Phase 3 HERO/OLE Data
Yahoo Finance ·
Aardvark Therapeutics, Inc. key financials
| USD | 2025 | 2024 |
|---|---|---|
| Net income | -$57.6M | -$20.6M |
| Diluted EPS | $-2.93 | $-5.15 |
| Total assets (year end) | $117.2M | $77.5M |
| Cash and equivalents (year end) | $47.1M | $61.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Aardvark Therapeutics, Inc.
- Ticker
- AARD (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1774857
Frequently asked questions
What exchange is Aardvark Therapeutics, Inc. listed on?
Aardvark Therapeutics, Inc. trades on the Nasdaq under the ticker symbol AARD.
What industry is Aardvark Therapeutics, Inc. in?
Aardvark Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Aardvark Therapeutics, Inc. headquartered?
Aardvark Therapeutics, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Aardvark Therapeutics, Inc.'s fiscal year end?
Aardvark Therapeutics, Inc.'s fiscal year ends on December 31.